The cytokine network in colorectal cancer: Implications for new treatment strategies
H Braumüller, B Mauerer, J Andris, C Berlin, T Wieder… - Cells, 2022 - mdpi.com
Colorectal cancer (CRC) is one of the most frequent tumor entities worldwide with only
limited therapeutic options. CRC is not only a genetic disease with several mutations in …
limited therapeutic options. CRC is not only a genetic disease with several mutations in …
Interleukins profiling for biosensing applications: possibilities and the future of disease detection
Interleukins (ILs) are a major subclass of cytokines acting as molecular messengers playing
role in immune system responses via a cascade of signaling pathways. Belonging to the …
role in immune system responses via a cascade of signaling pathways. Belonging to the …
[HTML][HTML] Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact
M Braoudaki, MS Ahmad, D Mustafov, S Seriah… - Seminars in Cancer …, 2022 - Elsevier
Colorectal cancer (CRC) is considered the second cause of cancer death worldwide. The
early diagnosis plays a key role in patient prognosis and subsequently overall survival …
early diagnosis plays a key role in patient prognosis and subsequently overall survival …
γδ T cells for leukemia immunotherapy: new and expanding trends
MS Barros, ND de Araújo, F Magalhães-Gama… - Frontiers in …, 2021 - frontiersin.org
Recently, many discoveries have elucidated the cellular and molecular diversity in the
leukemic microenvironment and improved our knowledge regarding their complex nature …
leukemic microenvironment and improved our knowledge regarding their complex nature …
Gene-edited interleukin CAR-T cells therapy in the treatment of malignancies: present and future
Z Zhang, L Miao, Z Ren, F Tang, Y Li - Frontiers in immunology, 2021 - frontiersin.org
In recent years, chimeric antigen receptor T cells (CAR-T cells) have been faced with the
problems of weak proliferation and poor persistence in the treatment of some malignancies …
problems of weak proliferation and poor persistence in the treatment of some malignancies …
Opposing functions of circadian protein DBP and atypical E2F family E2F8 in anti-tumor Th9 cell differentiation
Abstract Interleukin-9 (IL-9)-producing CD4+ T helper cells (Th9) have been implicated in
allergy/asthma and anti-tumor immunity, yet molecular insights on their differentiation from …
allergy/asthma and anti-tumor immunity, yet molecular insights on their differentiation from …
The World according to IL-9
Among the cytokines regulating immune cells, IL-9 has gained considerable attention for its
ability to act on multiple cell types as a regulator of beneficial and pathologic immune …
ability to act on multiple cell types as a regulator of beneficial and pathologic immune …
The janus face of IL-33 signaling in tumor development and immune escape
MR Choi, JA Sosman, B Zhang - Cancers, 2021 - mdpi.com
Simple Summary Interleukin-33 (IL-33) is often released from damaged cells, acting as a
danger signal. IL-33 exerts its function by interacting with its receptor suppression of …
danger signal. IL-33 exerts its function by interacting with its receptor suppression of …
Anti-tumorigenic activities of IL-33: a mechanistic insight
S Andreone, AR Gambardella, J Mancini… - Frontiers in …, 2020 - frontiersin.org
Interleukin-33 (IL-33) is an epithelial-derived cytokine that can be released upon tissue
damage, stress, or infection, acting as an alarmin for the immune system. IL-33 has long …
damage, stress, or infection, acting as an alarmin for the immune system. IL-33 has long …
Fatty acid oxidation in immune function
F Kemp, EL Braverman, CA Byersdorfer - Frontiers in immunology, 2024 - frontiersin.org
Cellular metabolism is a crucial determinant of immune cell fate and function. Extensive
studies have demonstrated that metabolic decisions influence immune cell activation …
studies have demonstrated that metabolic decisions influence immune cell activation …